Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.12 Million ≈ $1.33 Million USD) by net assets (CN¥910.35 Million ≈ $133.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. to measure how many days the company can operate on defensive assets alone.
Shenzhen Bioeasy Biotechnology Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rechi Precision Co Ltd
TW:4532
|
0.125x |
|
Svedbergs i Dalstorp AB (publ)
ST:SVED-B
|
-0.028x |
|
Grupo Rotoplas SAB de CV
MX:AGUA
|
0.082x |
|
HAXC Holdings (Beijing) Co. Ltd.
SHE:300928
|
N/A |
|
Shandong Hongyu Agricultural Machinery Co Ltd
SHE:002890
|
-0.003x |
|
RF Materials Co. Ltd
KQ:327260
|
0.014x |
|
Rice Acquisition Corporation 3
NYSE:KRSP
|
-0.001x |
|
Liaoning He Eye Hospital Group Co. LTD.
SHE:301103
|
N/A |
Annual Cash Flow Conversion Efficiency for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Shenzhen Bioeasy Biotechnology Co. Ltd..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥907.68 Million ≈ $132.82 Million |
CN¥66.87 Million ≈ $9.79 Million |
0.074x | +87.15% |
| 2024-12-31 | CN¥870.24 Million ≈ $127.34 Million |
CN¥34.26 Million ≈ $5.01 Million |
0.039x | +189.70% |
| 2023-12-31 | CN¥848.73 Million ≈ $124.20 Million |
CN¥-37.25 Million ≈ $-5.45 Million |
-0.044x | -127.75% |
| 2022-12-31 | CN¥964.70 Million ≈ $141.17 Million |
CN¥152.55 Million ≈ $22.32 Million |
0.158x | -41.40% |
| 2021-12-31 | CN¥946.58 Million ≈ $138.51 Million |
CN¥255.42 Million ≈ $37.38 Million |
0.270x | +132.21% |
| 2020-12-31 | CN¥548.98 Million ≈ $80.33 Million |
CN¥63.79 Million ≈ $9.34 Million |
0.116x | -8.70% |
| 2019-12-31 | CN¥528.32 Million ≈ $77.31 Million |
CN¥67.24 Million ≈ $9.84 Million |
0.127x | -51.09% |
| 2018-12-31 | CN¥222.62 Million ≈ $32.58 Million |
CN¥57.93 Million ≈ $8.48 Million |
0.260x | +26.35% |
| 2017-12-31 | CN¥114.60 Million ≈ $16.77 Million |
CN¥23.60 Million ≈ $3.45 Million |
0.206x | -68.67% |
| 2016-12-31 | CN¥55.24 Million ≈ $8.08 Million |
CN¥36.31 Million ≈ $5.31 Million |
0.657x | -- |
About Shenzhen Bioeasy Biotechnology Co. Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more